The DOI matches its Crossref record; 250 of the 252 references it cites were found in a registry or an index.
Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges
Open accessAbstract
There is considerable interest in the pathobiology of tau protein, given its potential role in neurodegenerative diseases and aging. Tau is an important microtubule associated protein, required for the assembly of tubulin into microtubules and maintaining structural integrity of axons. Tau has other diverse cellular functions involving signal transduction, cellular proliferation, developmental neurobiology, neuroplasticity, and synaptic activity. Alternative splicing results in tau isoforms with differing microtubule binding affinity, differing representation in pathological inclusions in certain disease states, and differing roles in developmental biology and homeostasis. Tau haplotypes confer differing susceptibility to neurodegeneration. Tau phosphorylation is a normal metabolic process, critical in controlling tau’s binding to microtubules, and is ongoing within the brain at all times. Tau may be hyperphosphorylated, and may aggregate as detectable fibrillar deposits in tissues, in both aging and neurodegenerative disease. The hypothesis that p-tau is neurotoxic has prompted constructs related to isomers, low-n assembly intermediates or oligomers, and the “tau prion”. Human postmortem studies have elucidated broad patterns of tauopathy, with tendencies for those patterns to differ as a function of disease phenotype. However, there is extensive overlap, not only between genuine neurodegenerative diseases, but also between aging and disease. Recent studies highlight uniqueness to pathological patterns, including a pattern attributed to repetitive head trauma, although clinical correlations have been elusive. The diagnostic process for tauopathies and neurodegenerative diseases in general is challenging in many respects, and may be particularly problematic for postmortem evaluation of former athletes and military service members.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tau phosphorylation at threonine 231 is one of the earliest events in the cascade of phosphorylation,57 that modulates tubulin assembly.58”
From Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease (2022) · cites this paper as [57]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,018
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 1×
“unless the pathology is end-stage [119].”
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
Flagged first, then by citations
2 of the 252 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Brion JP, 1985, Arch Biol, 95, 229
- Himmler A, 1989, Mol Cell Biol, 9, 1389
- Smith MA, 1994, Neurobiology, 91, 5710
- Mandelkow EM, 2011, Cold Spring Harb Perspect Biol, 3, 1
- Millspaugh JA, 1937, U S Nav Med Bull, 35, 297
- Roberts A, 1969, Brain damage in boxers: A study of prevalance of traumatic encephalopathy among exprofessional boxers
- Allsop D, 1990, Am J Pathol, 136, 255
- Nowak La, 2009, Clin Neuropathol, 28, 275
- Riedl L, 2014, Neuropsychiatr Dis Treat, 10, 297
Cited by
Sorted by citations
Items 101–110 of 110
Zamorano, M., Alexander, J. F., Catania, D., Dharmaraj, S., Kavelaars, A., & Heijnen, C. J. (2024) · Figshare · doi:10.6084/m9.figshare.26564046
Zamorano, M., Alexander, J. F., Catania, D., Dharmaraj, S., Kavelaars, A., & Heijnen, C. J. (2024) · Figshare · doi:10.6084/m9.figshare.26564043
Zamorano, M., Alexander, J. F., Catania, D., Dharmaraj, S., Kavelaars, A., & Heijnen, C. J. (2024) · Figshare · doi:10.6084/m9.figshare.26564040
Zamorano, M., Alexander, J. F., Catania, D., Dharmaraj, S., Kavelaars, A., & Heijnen, C. J. (2024) · Figshare · doi:10.6084/m9.figshare.26564049
Dakhel, A., Mothes, T., Eltom, K., Michno, W., & Erlandsson, A. (2026) · iScience · doi:10.1016/j.isci.2026.115819
Loizidou, M. A., Christoforou, C., & Constantinidou, F. (2026) · Brain Communications · doi:10.1093/braincomms/fcag149
Endogenous Neurotoxicity: A Pathophysiological Consequence of Homeostatic Dysfunction
Yanglem, S., Loushambam, B., Singh, S. M., & Vijayaraghavalu, S. (2026) · Neuroglia · doi:10.3390/neuroglia7030029
Studying the Neural Basis for Cognition, Memory, and Pathology Using Microdialysis
Fecik, M. J., Day, S. M., & Savage, L. M. (2026) · Neuromethods · doi:10.1007/978-1-0716-5122-3_9
Tau Isoform Expression Drives Disease Outcomes Following a Single Closed Head InjuryPreprint
Furhang, R., Morrone, R., Nikulina, E., Jere, M., Kaur, A., Nayab, F., Saito, T., Saido, T. C., & Bergold, P. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.08.737276
Papini, M. G., Thorne, J., Gozt, A., Avila, A. N., Beaton, C. S., Gilroy, R., Gill, G., Buhagiar, F., Thomas, E., Armstrong, A., et al. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14060-0
Metadata
- Authors
- Castellani, R. J., & Perry, G.
- Affiliations
- West Virginia University (US)
- The University of Texas at San Antonio (US)
- Corresponding author
- Castellani, Rudy J.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2018-12-18
- Volume
- 67
- Issue
- 2
- Pages
- 447-467
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC6398540
- OpenAlex
- W2906559084
- Cited by
- 110
- References
- 252
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 9 · 2023: 18 · 2022: 13 · 2021: 23 · 2020: 17 · 2019: 4
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, tauopathy
- MeSH terms
- Brain Injuries, Traumatic, Animals, Humans, tau Proteins, Neurodegenerative Diseases, Tauopathies, Post-Concussion Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
